Richard Scolyer Professorial Chair in Brain Cancer Research

Purpose and Program Overview

The Richard Scolyer Professorial Chair in Brain Cancer Research program is a strategic health and medical research initiative established to strengthen national research capacity in Australia. The grant intends to accelerate scientific work in a high-priority cancer field by supporting a designated research leadership role. The primary objective is to drive advancements in brain cancer research, expand local clinical trials, and effectively translate new laboratory discoveries into tangible patient outcomes.

The program supports a dedicated medical research position established at the Chris O’Brien Lifehouse in Sydney, Australia. By integrating top-tier clinical expertise with structural funding, the program plays a vital role in advancing medical innovation and fostering collaboration across the biotechnology, healthcare, and pharmaceutical industries. This centralised leadership framework helps build a sustainable pipeline for medical research translation within the Australian healthcare economy.

The position honours Professor Richard Scolyer AO, the joint 2024 Australian of the Year and a world-renowned pathologist who revolutionised melanoma treatment globally. Following his diagnosis with glioblastoma, an aggressive form of brain cancer, Professor Scolyer became the first patient globally to receive combination immunotherapy before surgery and a personalised vaccine. This therapeutic strategy was adapted directly from his prior breakthrough melanoma research, establishing a profound medical legacy that this chair seeks to continue.

Key Grant Details

• Grant Amount: A total investment value of $5.9 million.
• Application Dates: Open and close timelines are determined by the administering institutional partners.
• Eligible Industries: Medical research, tertiary education, healthcare services, and clinical oncology.
• Required Co-contributions: Supported by an institutional partnership involving the University of Sydney and Royal Prince Alfred Hospital.
• Location Applicability: Based in Sydney, New South Wales, with national research capacity outcomes across Australia.

Priority Sectors

The program explicitly targets the health, medical research, and clinical oncology sectors. It focuses specifically on specialised research leadership and translational development within the brain cancer research domain.

Funding Scope

The total $5.9 million investment from the Australian Federal Government is structured to fund a comprehensive research team and research capability infrastructure. The funding allocation is broken down into specific streams:

• The primary salary and operational overheads for the designated Professorial Chair.
• Salaries and research support for postdoctoral fellows.
• Operational funding for research assistants.
• Dedicated PhD scholarships to build long-term scientific capacity.

Eligibility Criteria

To align with the program’s structural requirements, participating entities and individuals must satisfy the following core criteria:

• Designated Research Setting: The position must be physically and operationally hosted at the Chris O’Brien Lifehouse in Sydney.
• Institutional Affiliation: Must maintain direct operational and academic partnerships with the University of Sydney and the Royal Prince Alfred Hospital.
• Compliance Status: Organisations must hold valid registrations, active Australian Business Numbers (ABNs), and meet national medical research compliance guidelines.

Eligible Activities and Expenses

The financial support provided by this grant must be applied directly to core research personnel and training streams. Eligible expenses include:

• Fully funding the Chair’s professional salary.
• Employment costs for postdoctoral fellows and technical research assistants.
• Stipends and tuition support for dedicated PhD research scholarships.
• Operational activities directly tied to expanding brain cancer clinical trials and laboratory translation.

Assessment Process

The program operates under a structured institutional appointment and evaluation process overseen by the Australian Federal Government and its university partners. Applications and research performance are evaluated against core parameters:

• Project Merit: The scientific viability and clinical potential of the proposed brain cancer research streams.
• Strategic Alignment: The capacity to strengthen national research framework objectives and accelerate work in high-priority fields.
• Value for Money: Efficient allocation of the $5.9 million investment across personnel deployment and clinical trial expansion.

Recent Program Updates

The program was formally established through a $5.9 million federal investment. This funding underpins the specialised infrastructure required to run the personalised vaccine and immunotherapy trials pioneered by the chair’s namesake, translating melanoma treatment breakthroughs directly into glioblastoma clinical workflows.

Application Tips

• Verify Institutional Alignment: Ensure all research proposals fit directly within the joint operational frameworks of the University of Sydney and Royal Prince Alfred Hospital.
• Document Personnel Capability: Clearly outline how postdoctoral fellows and PhD scholars will be integrated into the broader clinical trial pipeline.
• Align with Federal Priorities: Structure research outcomes to target clear, measurable improvements in clinical trial expansion and translational patient metrics.
• Demonstrate Collaborative Capacity: Provide clear evidence of the ability to bridge laboratory discoveries with active clinical hospital environments.

Where to Get Help

Consider consulting a grant specialist like Pattens Group for a personalised eligibility assessment and expert assistance in preparing a strong, compliant and competitive application. Contact us today and get connected with Australia’s best grant specialist, boasting over 35 years of experience in the industry and a 100% success rate. For official guidelines, application details, templates, and further information, visit the official website of the Richard Scolyer Professorial Chair in Brain Cancer Research program and other associated Australian government websites.